These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9326467)
21. Current trends in onychomycosis therapy: a literature review. Hecker D Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835 [TBL] [Abstract][Full Text] [Related]
22. New drugs for the nail fungus prevalent in elderly. Phillips P JAMA; 1996 Jul; 276(1):12-3. PubMed ID: 8667524 [No Abstract] [Full Text] [Related]
23. Facing up to the diagnostic uncertainty and management of onychomycoses. Arrese JE; Piérard-Franchimont C; Piérard GE Int J Dermatol; 1999 Sep; 38 Suppl 2():1-6. PubMed ID: 10515522 [No Abstract] [Full Text] [Related]
24. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. Yin Z; Xu J; Luo D J Dermatolog Treat; 2012 Dec; 23(6):449-52. PubMed ID: 21801094 [TBL] [Abstract][Full Text] [Related]
25. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta AK; Lynde CW; Konnikov N J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119 [TBL] [Abstract][Full Text] [Related]
26. The new oral antifungal agents for onychomycosis of the toenails. Gupta AK; Shear NH J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624 [TBL] [Abstract][Full Text] [Related]
27. Current treatment of onychomycosis. Thappa DM Indian J Dermatol Venereol Leprol; 2007; 73(6):373-6. PubMed ID: 18032853 [No Abstract] [Full Text] [Related]
28. Itraconazole and terbinafine in perspective. From petri dish to patient. De Doncker P; Gupta AK Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660 [TBL] [Abstract][Full Text] [Related]
29. New antifungal therapy for children. Suarez S Adv Dermatol; 1997; 12():195-208; discussion 209. PubMed ID: 8973741 [No Abstract] [Full Text] [Related]
30. Toenail onychomycosis: current and future treatment options. Finch JJ; Warshaw EM Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258 [TBL] [Abstract][Full Text] [Related]
31. Terbinafine: a review of its use in onychomycosis in adults. Darkes MJ; Scott LJ; Goa KL Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372 [TBL] [Abstract][Full Text] [Related]
33. The systemic treatment of onychomycosis. Wenig JA Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500 [TBL] [Abstract][Full Text] [Related]
34. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Gupta AK; Ryder JE; Johnson AM Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339 [TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis. Salo H; Pekurinen M Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041 [TBL] [Abstract][Full Text] [Related]
36. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
37. An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents. Gupta AK; Del Rosso JQ Int J Dermatol; 2000 Jun; 39(6):401-11. PubMed ID: 10944084 [No Abstract] [Full Text] [Related]
38. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis. Safer LF Acta Derm Venereol; 2000; 80(4):317-8. PubMed ID: 11028880 [No Abstract] [Full Text] [Related]